Rob Shaffer

Company: Enable Therapeutics

Job title: Founder

Seminars:

Targeting Glycogen in Childhood Dementia with Expansion Potential to Larger Neurodegenerative Indications 1:03 pm

Childhood dementias such as Lafora Disease (LD) are fatal and fewer than 5% have effective treatments An antibody-enzyme fusion clears accumulated pathogenic glycogen in the brain of LD animal models, rescuing metabolism and glycosylation patterns Highlights a putative strategy for currently untreatable neurodegenerative diseases with demonstrated elevated glycogenRead more

day: Pre-Conference Discussion Day